-
Nurofen Plus – Warning on prolonged use at higher than recommended doses
Oct 21, 2022, 00:00 -
Topamax (topiramate) – Ongoing EU review of potential risk of NDD
Oct 18, 2022, 00:00 -
How to report adverse reactions to vaccines – MIMS – Reminder article
Oct 1, 2022, 00:00 -
Methylphenidate – MIMS – Risk of cardiac malformations in infants
Oct 1, 2022, 00:00 -
PRAC meeting highlights 26-29 September 2022
Sep 26, 2022, 00:00 -
Pregabalin – MIMS – Expanded warning regarding drug dependence and withdrawal symptoms
Sep 1, 2022, 00:00 -
Optimising safe and effective use of medicines – IMF – Proactive risk management
Sep 1, 2022, 00:00 -
Adverse Reaction Reporting – MIMS – Reminder on how to report to the HPRA
Sep 1, 2022, 00:00 -
PRAC meeting highlights 29 August - 1 September 2022
Aug 29, 2022, 00:00 -
Rubraca (rucaparib) – Restriction of indication
Aug 12, 2022, 00:00 -
Drug Safety Newsletter – Edition 108 – 10 August 2022
Aug 10, 2022, 00:00 -
Hiprabovis IBR marker live vaccine – Changes to precautions for use
Jul 25, 2022, 11:01 -
MiniMed 600 and 700 Series Insulin Pumps – Priority 2 – Warning
Jul 19, 2022, 00:00 -
Genrui SARS-CoV-2 Antigen Self-Test Kit (Colloidal Gold) – Priority 1 – For Immediate Action
Jan 18, 2022, 00:00
